• ERK5/MAPK and MEK1/2 Pathway Roles in Vitamin D3-Induced Mye

  2026-06-12

  This study uncovers the distinct and complementary roles of ERK5 and MEK1/2-ERK1/2 signaling in mediating terminal differentiation of acute myeloid leukemia (AML) cells in response to 1α,25-dihydroxyvitamin D3. The findings highlight the potential for combinatorial pathway targeting to enhance the anti-leukemic effects of vitamin D derivatives and underscore the importance of dissecting MAPK signaling complexity for translational cancer research.

• Optimizing ARCA Capped mRNA Synthesis with HyperScribe Kit P

  2026-06-12

  The HyperScribe Co-transcription mRNA Synthesis Kit Plus streamlines high-yield, ARCA-capped, polyadenylated mRNA production for advanced molecular applications. Its robust design delivers reproducibility and translational efficiency crucial for RNA vaccine development, in vitro translation assays, and RNAi workflows.

• Epinephrine Concentration in Local Anesthesia: Systemic Effe

  2026-06-11

  This review examines the physiological effects, systemic risks, and optimal concentrations of epinephrine as a vasoconstrictor in dental local anesthesia. Its findings clarify the balance between anesthetic efficacy and systemic safety, providing an evidence-based foundation for both clinical and experimental protocol design.

• FITC-Concanavalin A (ConA) Conjugate: Protocol and Workflow

  2026-06-11

  FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces, supporting research in immunofluorescence staining and flow cytometry. It should be used exclusively for carbohydrate-binding assays, following defined storage and stability guidelines for reliable results.

• FITC-Concanavalin A (ConA) Conjugate: Practical Lab Protocol

  2026-06-10

  FITC-Concanavalin A (ConA) Conjugate provides a reliable, fluorescence-based probe for detecting α-D-glucose and α-D-mannose residues on cell surfaces. It is specifically suited for immunofluorescence staining and flow cytometry carbohydrate detection workflows in glycobiology. This reagent should not be used outside carbohydrate-binding assays or beyond its defined stability period.

• Tomivosertib: MNK1 Inhibitor Workflows and Troubleshooting G

  2026-06-10

  Tomivosertib, a potent and selective MNK1 inhibitor, enables precise dissection of the MNK-eIF4E signaling axis in oncology and neurobiology. This article delivers actionable workflow enhancements, protocol benchmarks, and expert troubleshooting tips, making it essential for researchers aiming for reproducible and translationally relevant results.

• Coumestrol Induces Ferroptosis in RA Synoviocytes via PMAIP1

  2026-06-09

  The referenced study demonstrates that Coumestrol, a phytoestrogen estrogen receptor antagonist, suppresses proliferation and inflammation in rheumatoid arthritis fibroblast-like synoviocytes by inducing ferroptosis through stabilization of mitochondrial PMAIP1. These findings reveal a mechanistic link between selective estrogen receptor modulation and ferroptosis in autoimmune disease models, providing new directions for targeted therapeutic strategies.

• Fulvestrant (ICI 182,780): Mechanisms and Benchmarks in ER+

  2026-06-09

  Fulvestrant (ICI 182,780) is a potent estrogen receptor antagonist used in advanced ER-positive breast cancer. It induces degradation of ERα and MDM2 proteins, sensitizes tumor cells to chemotherapy, and is a benchmark agent for endocrine therapy resistance research. APExBIO provides validated product quality and protocols for reproducible translational research.

• 2,2,2-Trichloroethanol: Small Molecule Biochemical for Prote

  2026-06-08

  2,2,2-Trichloroethanol empowers protein analysis workflows and molecular biology research in ways standard reagents cannot, enabling rapid, sensitive detection and workflow optimization. Its high solubility and purity from APExBIO support reproducible, data-driven advances in dopaminergic neuron studies and beyond.

• Trilaurin (Glycerol Tridodecanoate): Applied Workflows & Pro

  2026-06-08

  Trilaurin (Glycerol Tridodecanoate) is a versatile lipid excipient enabling advanced drug delivery, reproducible biocatalytic synthesis, and cosmetic formulation. Distinct in its lack of skin sensitization and high yield in enzymatic workflows, Trilaurin from APExBIO stands out for formulation reliability and experimental flexibility.

• Iptacopan (LNP023): Applied Workflows in Complement Research

  2026-06-07

  Iptacopan (LNP023) empowers researchers to selectively inhibit the alternative complement pathway in both in vitro and in vivo models, delivering precise control over complement activation. This article details advanced use-cases, protocol enhancements, and troubleshooting strategies, translating recent reference findings into actionable workflows for complement-mediated disease research.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Use Guide

  2026-06-06

  The Anti-HMGB1 Rabbit Monoclonal Antibody (MA3057) provides a validated, species-cross-reactive tool for precise detection of HMGB1 protein in human, mouse, and rat research samples. It is designed for use in Western blot, immunohistochemistry, and flow cytometry workflows targeting chromatin protein studies, but is not validated for diagnostic or therapeutic applications.

• Optimizing Cancer Epigenetics with GSK126 EZH2 Inhibitor (SK

  2026-06-05

  This article delivers scenario-driven, evidence-based guidance on deploying GSK126 EZH2 inhibitor (SKU A3446) for robust, reproducible epigenetic assays in cancer research. By addressing common laboratory challenges and contrasting real-world solutions, it demonstrates how this selective small molecule from APExBIO empowers workflows in oncology and functional genomics.

• Microfluidized Dextran–Trilaurin LNP System for Oral Colon C

  2026-06-05

  This study presents a hierarchically targeted oral delivery system combining microfluidized dextran microgels and trilaurin-based lipid nanoparticles to co-deliver cisplatin and SPIONs for localized colon cancer treatment. The approach demonstrates enhanced tumor targeting, improved drug retention in the colon, and effective dual chemo-magnetothermal therapy, with implications for peptide/protein drug oral delivery and nanoparticle-based cancer therapeutics.

• Technical Guide: FITC-Concanavalin A (ConA) Conjugate Applic

  2026-06-04

  FITC-Concanavalin A (ConA) Conjugate enables targeted detection of cell surface α-D-glucose and α-D-mannose residues in immunofluorescence and flow cytometry workflows. It should be used exclusively for carbohydrate-binding applications, and not for non-glycan targets or outside its defined storage and stability parameters.

16484 records 1/1099 page Next 12345 下5页 Last page